Aileron Therapeutics, Inc.(ALRN) a Boston-based biopharmaceutical company Friday has announced that it has rebranded itself into Rein Therapeutics, Inc. The updated name, logo, website, and branding represent the Company's mission to create breakthrough treatments to combat diseases.
ALRN's stock will start to trade under the Nasdaq ticker "RNTX" from January 13, 2025. The CUSIP number for the company's common stock remains unchanged.
Currently, is trading at $2.01 or 4.1451% higher on the Nasdaq Capital Market.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.